BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29868247)

  • 21. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].
    Oberndorfer S; Schmal T; Lahrmann H; Urbanits S; Lindner K; Grisold W
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):911-6. PubMed ID: 12528323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
    Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
    J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.
    Scott CB; Nelson JS; Farnan NC; Curran WJ; Murray KJ; Fischbach AJ; Gaspar LE; Nelson DF
    Cancer; 1995 Jul; 76(2):307-13. PubMed ID: 8625107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Prognosis of High-Grade gliomas in the View of New Immunohistochemistry Markers and 2016 WHO Classification.
    Dolen D; Ahmadov T; Dolas I; Unal TC; Aydoseli A; Ozturk M; Sabanci PA; Aras Y; Bilgic MB; Sencer A
    Turk Neurosurg; 2022; 32(3):500-507. PubMed ID: 35615769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
    Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
    Vizcaino MA; Palsgrove DN; Yuan M; Giannini C; Cabrera-Aldana EE; Pallavajjala A; Burger PC; Rodriguez FJ
    Brain Pathol; 2019 Mar; 29(2):193-204. PubMed ID: 30222900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
    Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma Multiforme of the Conus Medullaris-Management Strategies and Complications.
    Goodarzi A; Thaci B; Toussi A; Karnati T; Kim K; Fragoso R
    World Neurosurg; 2019 Apr; 124():101-109. PubMed ID: 30639501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.